Fineline Cube

Follow:
14778 Articles
Hua Medicine's SENSITIZE Study Illuminates Dorzagliatin's β-Cell Glucose Sensitivity Mechanism
CompanyDrug

Hua Medicine’s SENSITIZE Study Illuminates Dorzagliatin’s β-Cell Glucose Sensitivity Mechanism

Sunflower Pharmaceutical Group to Establish Joint Lab with Peking University for Bacterial Enzyme Research
CompanyDeals

Sunflower Pharmaceutical Group to Establish Joint Lab with Peking University for Bacterial Enzyme Research

Simcere Pharmaceutical's Edaravone and Borneol Sublingual Tablets Approved for AIS Treatment in China
CompanyDrug

Simcere Pharmaceutical’s Edaravone and Borneol Sublingual Tablets Approved for AIS Treatment in China

Shanghai Pharmaceuticals Concludes Phase II Study for I037 in Acute Ischemic Stroke
CompanyDrug

Shanghai Pharmaceuticals Concludes Phase II Study for I037 in Acute Ischemic Stroke

Affinity (Shanghai) Secures Over RMB 400 Million in Series B2 Financing to Advance Oncology Drugs
CompanyDeals

Affinity (Shanghai) Secures Over RMB 400 Million in Series B2 Financing to Advance Oncology Drugs

Abogen Biosciences and Ruijin Hospital Launch Ruijin Abogen Nucleic Acid Drug Research Institute
CompanyDeals

Abogen Biosciences and Ruijin Hospital Launch Ruijin Abogen Nucleic Acid Drug Research Institute

Henlius Biotech Initiates US Commercial Supply of Hanquyou, Biosimilar to Herceptin
CompanyDrug

Henlius Biotech Initiates US Commercial Supply of Hanquyou, Biosimilar to Herceptin

ImmuneOnco Biopharmaceuticals Receives NMPA Approval for Lupus Nephritis Phase II Study
CompanyDrug

ImmuneOnco Biopharmaceuticals Receives NMPA Approval for Lupus Nephritis Phase II Study

Healthgen Biotechnology's Plant-Made Albumin Breakthrough: A Milestone in Serum Therapy
CompanyDrug

Healthgen Biotechnology’s Plant-Made Albumin Breakthrough: A Milestone in Serum Therapy

Shanghai Cell Therapy Group's Second Attempt at HK IPO Receives Green Light from CICC and CCB International
Company

Shanghai Cell Therapy Group’s Second Attempt at HK IPO Receives Green Light from CICC and CCB International

Nanjing Leads Biolabs Commences IPO Process with Focus on Innovative Therapies
Company

Nanjing Leads Biolabs Commences IPO Process with Focus on Innovative Therapies

XellSmart Bio-Pharmaceutical Achieves Milestone with First Patient Enrollment in Global iPSC Clinical Study for ALS
CompanyDrug

XellSmart Bio-Pharmaceutical Achieves Milestone with First Patient Enrollment in Global iPSC Clinical Study for ALS